Difficult management of abnormal uterine bleeding in Glanzmann thrombasthenia
This paper describes the challenging medical and surgical management of abnormal uterine bleeding in two patients with the rare hematological disorder Glanzmann thrombasthenia.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This paper reports two case histories of patients with Glanzmann thrombasthenia presenting with abnormal uterine bleeding, a condition caused by impaired platelet aggregation due to defects in glycoprotein IIb/IIIa. Across the cases, clinicians used different approaches to control heavy menstrual bleeding, including medical management with tranexamic acid and hormonal therapy in one patient and surgical treatment for a tubo-ovarian endometrioma with laparoscopic adhesiolysis and cyst aspiration in the other, addressing heavy bleeding and dysmenorrhoea. The authors note that the rarity of Glanzmann thrombasthenia makes prevention and control of bleeding challenging and that these are case reports, which should not be used in isolation to guide treatment choices. Relevance to endometriosis: the paper’s second case involves a tubo-ovarian endometrioma presenting with heavy menstrual bleeding and dysmenorrhoea, though the paper’s main focus is difficult abnormal uterine bleeding management in Glanzmann thrombasthenia rather than endometriosis or adenomyosis broadly.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
1,987 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
SciLite annotations
chemicals 1
Source provenance
- europepmc
- last seen: 2026-06-17T06:13:18.893374+00:00
- pubmed
- last seen: 2026-06-17T06:10:25.567277+00:00
- scilite
- last seen: 2026-05-18T04:26:01.642840+00:00
- unpaywall
- last seen: 2026-05-11T08:34:28.763810+00:00
Courtesy of the U.S. National Library of Medicine